Programs

HomePrograms ▶ ATS/CHEST Foundation Research Grant in Diversity
ATS/CHEST Foundation Research Grant in Diversity

Important Notes

Applicants are strongly advised to read the instructions and eligibility criteria before starting an application.
This grant does not have a letter of intent (LOI) stage - you do not need to be invited to submit a full application.


Anticipated Timeline

March 31, 2020 Applications accepted through Foundant Technologies
June 23, 2020 Deadline for Full Application due by 11:59 pm Eastern Time
August 2020 Grantee Notification
September 2020 Grant Start Date

 CHEST Foundation Logo

ATS/CHEST Foundation Research Grant in Diversity

1 grant available
$40,000 per year for 2 years

Target audience:
Investigators working on clinical research in the areas of pulmonary, critical care, or sleep medicine that disproportionately affect underrepresented minority (URM) patient groups.

The focus of this research grant is clinical research that contributes to the understanding of the pathophysiology or treatment of conditions related to pulmonary, critical care, or sleep medicine that disproportionately affects underrepresented minority (URM) patient groups. URM patient groups includes patients from lower-middle and low income countries as defined by the World Bank, or the following North American populations: African Americans, Mexican-Americans, Native Americans (American Indians, Alaska Natives, and native Hawaiians), Pacific Islanders, and mainland Puerto Ricans. Applicants may request up to $40,000 per year for two years for salaries, supplies, or a combination of these two. No more than 20% of the budget can be for salary. Funding may not be used for patient incentives and indirect costs will not be paid to the sponsoring institution.

Award-specific eligibility: 
• Junior investigators (as defined here) and applicants who are trainees (fellows)
• Applicants holding PhD, MD, RN, RRT, or PA degrees
• Must be a member of CHEST
• Must meet eligibility requirements for all ATS grants found here

Co-funded by the ATS and the CHEST Foundation. Please visit foundation.chestnet.org for more information about our partner.


Review Process

Please note that after you submit your application it will be reviewed by Research Program staff. If there are any problems or if these guidelines have not been followed, your proposal will be un-submitted. Please make sure that you check your email after you submit your application so that any outstanding issues may be addressed as quickly as possible.

The ATS Scientific Advisory Committee (SAC) will review the applications in July 2020. The membership of the SAC is listed on the ATS Website and additional ad hoc reviewers will be invited to participate as needed. Funding decisions will be made on the basis of scientific merit, novelty, and responsiveness to the purpose of the specific grant program.


ATS Policy on Additional Grant Funding

Simultaneous submission of grants with scientific overlap is allowed, but if multiple applications are funded, then the applicant must notify the Research Program within one month of formal notification of award. A subcommittee of the SAC will assess the degree of overlap. In the case of significant scientific overlap, the applicant will have to choose between the ATS research grant and the other grant. Budgetary overlap is not allowed.



If your question is not answered in the FAQ, contact the ATS Research Program at researchprogram@thoracic.org.

The American Thoracic Society improves global health by advancing research, patient care, and public health in pulmonary disease, critical illness, and sleep disorders. Founded in 1905 to combat TB, the ATS has grown to tackle asthma, COPD, lung cancer, sepsis, acute respiratory distress, and sleep apnea, among other diseases.

Twitter Facebook LinkedIn Instagram YouTube Social Media Page

AMERICAN THORACIC SOCIETY
25 Broadway
New York, NY 10004
United States of America

Phone: +1 (212) 315-8600
Fax: +1 (212) 315-6498
Email: atsinfo@thoracic.org

© 1998 - American Thoracic Society, all rights reserved.